We are live on
!
Find out more
CWM
Calamos Wealth Management Portfolio holdings
AUM
$2.91B
1-Year Est. Return
25.59%
This Fund
S&P 500
This Quarter
Est. Return
+2.92%
1 Year Est. Return
+25.59%
3 Year Est. Return
+81.71%
5 Year Est. Return
+106.72%
10 Year Est. Return
+362.79%
AUM
$707M
AUM Growth
+$37.8M
(+5.7%)
Cap. Flow
-$17.4M
Cap. Flow
% of AUM
-2.46%
Top 10 Holdings %
Top 10 Hldgs %
28.99%
Holding
244
New
15
Increased
97
Reduced
49
Closed
17
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$8.45M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$3.63M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.68M |
| 4 |
Chubb
CB
|
+$2.56M |
| 5 |
Prudential Financial
PRU
|
+$2.53M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$2.67M |
| 2 |
iShares MSCI EAFE Min Vol Factor ETF
EFAV
|
+$2.53M |
| 3 |
iShares S&P 100 ETF
OEF
|
+$2.24M |
| 4 |
Southwest Airlines
LUV
|
+$2.23M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.2M |
Sector Composition
| 1 | Financials | 13.43% |
| 2 | Technology | 10.58% |
| 3 | Healthcare | 8.08% |
| 4 | Communication Services | 7.69% |
| 5 | Industrials | 6.59% |
Similar funds
BAM
NRCM
SCM
HCC
ZF
CCPM
SCM
AG
Calamos Wealth Management's Q2 2017 Portfolio in Review
As of Q2 2017, Calamos Wealth Management held 244 positions worth $707M, up 5.7% from $669M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Calamos Wealth Management's Q2 2017 filing shows 15 new, 97 increased, 49 reduced and 17 closed positions. Its largest new stake was Chubb: 18,169 shares worth $2.64M. The largest sale was Gilead Sciences, an estimated $2.67M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.
- Calamos Wealth Management's largest Q2 2017 buy was Chubb: 18,169 shares worth $2.64M.
- Calamos Wealth Management added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $8.45M increase.
- Calamos Wealth Management's biggest Q2 2017 reduction was iShares MSCI EAFE Min Vol Factor ETF, cutting an estimated $2.53M.
- Calamos Wealth Management fully exited Gilead Sciences in Q2 2017, selling an estimated $2.67M.
- Calamos Wealth Management's ten largest holdings make up 29% of its $707M portfolio in Q2 2017.
- Calamos Wealth Management opened 15 new positions and closed 17 in Q2 2017.
- Calamos Wealth Management's portfolio value rose 5.7% quarter-over-quarter to $707M.
Based on Calamos Wealth Management's 13F filing for Q2 2017, filed 9 Aug 2017.